IL-6 is an early mediator and has a longer half-life period than TNFα and IL-1β and that intrinsic property makes it possible to use IL-6 as a marker of sepsis and SIRS [2, 10, 11]. The gene discussed is TNF; the disease is systemic inflammatory response syndrome.